EMD-12586

Single-particle
3.5 Å
EMD-12586 Deposition: 09/03/2021
Map released: 28/04/2021
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-12586

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7nta summary report (pdf.gz) Map-7nta FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)

EMD-12586

Single-particle
3.5 Å
EMD-12586 Deposition: 09/03/2021
Map released: 28/04/2021
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: Ectodomain of S1 protein from SARS-CoV-2 expressed in HEK cells and purified. Sample in the presence of excess biliverdin.
Fitted models: 7nta

Deposition Authors: Rosa A , Pye VE
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.
PUBMED: 33888467
DOI: doi:10.1126/sciadv.abg7607
ISSN: 2375-2548
Grant Support: